Birdwatch Note
2023-06-12 17:39:51 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
A nota mencionada neste tweet foi publicada em julho de 2021, em referência a uma publicação do FDA. Em 28/3/2023, a ANVISA publicou nota reforçando a segurança da vacina, e em 13/4/2023 emitiu nova nota reafirmando que todas as vacinas aprovadas permanecem válidas e seguras. https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2023/anvisa-esclarece-sobre-risco-de-miocardite-e-pericardite-pos-vacinacao https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2023/nota-anvisa-vacinas-contra-covid-19
Written by 7E89B08ED0C7BF36987C0D516A71E273A4C69D4661AD9C5279402CD4C298894A
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1668255345993474049
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1668312169794895877
- noteId - 1668312169794895877
- participantId -
- noteAuthorParticipantId - 7E89B08ED0C7BF36987C0D516A71E273A4C69D4661AD9C5279402CD4C298894A Participant Details
- createdAtMillis - 1686591591679
- tweetId - 1668255345993474049
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- A nota mencionada neste tweet foi publicada em julho de 2021, em referência a uma publicação do FDA. Em 28/3/2023, a ANVISA publicou nota reforçando a segurança da vacina, e em 13/4/2023 emitiu nova nota reafirmando que todas as vacinas aprovadas permanecem válidas e seguras. https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2023/anvisa-esclarece-sobre-risco-de-miocardite-e-pericardite-pos-vacinacao https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2023/nota-anvisa-vacinas-contra-covid-19
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-06-12 17:39:51 UTC (1686591591679) |
1969-12-31 23:59:59 UTC (-1) |
2023-06-13 02:10:50 UTC (1686622250242) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-06-12 19:10:09 -0500 | Rating Details | |
2023-06-12 18:55:15 -0500 | Rating Details | |
2023-06-12 18:34:11 -0500 | Rating Details | |
2023-06-12 18:14:59 -0500 | Rating Details | |
2023-06-12 17:31:43 -0500 | Rating Details | |
2023-06-12 17:24:45 -0500 | Rating Details | |
2023-06-12 17:14:19 -0500 | Rating Details | |
2023-06-12 16:43:43 -0500 | Rating Details | |
2023-06-12 16:26:54 -0500 | Rating Details | |
2023-06-12 15:20:49 -0500 | Rating Details | |
2023-06-12 14:59:16 -0500 | Rating Details | |
2023-06-12 14:47:37 -0500 | Rating Details | |
2023-06-12 14:34:28 -0500 | Rating Details | |
2023-06-12 13:58:33 -0500 | Rating Details | |
2023-06-12 13:10:58 -0500 | Rating Details | |
2023-06-12 12:43:19 -0500 | Rating Details | |
2023-06-13 15:47:26 -0500 | Rating Details | |
2023-06-13 15:41:07 -0500 | Rating Details | |
2023-06-13 14:30:42 -0500 | Rating Details | |
2023-06-13 11:57:16 -0500 | Rating Details | |
2023-06-13 11:15:24 -0500 | Rating Details | |
2023-06-13 10:01:18 -0500 | Rating Details | |
2023-06-13 09:27:09 -0500 | Rating Details | |
2023-06-13 08:28:50 -0500 | Rating Details | |
2023-06-13 06:35:17 -0500 | Rating Details | |
2023-06-13 06:15:08 -0500 | Rating Details | |
2023-06-13 06:07:21 -0500 | Rating Details | |
2023-06-13 05:10:03 -0500 | Rating Details | |
2023-06-13 05:04:52 -0500 | Rating Details | |
2023-06-13 04:59:47 -0500 | Rating Details | |
2023-06-13 04:15:06 -0500 | Rating Details | |
2023-06-13 03:29:08 -0500 | Rating Details | |
2023-06-13 02:27:29 -0500 | Rating Details | |
2023-06-13 02:05:12 -0500 | Rating Details | |
2023-06-13 01:31:09 -0500 | Rating Details | |
2023-06-13 01:04:40 -0500 | Rating Details | |
2023-06-12 23:11:25 -0500 | Rating Details | |
2023-06-12 22:48:40 -0500 | Rating Details | |
2023-06-12 22:45:42 -0500 | Rating Details | |
2023-06-12 22:20:22 -0500 | Rating Details | |
2023-06-12 20:47:05 -0500 | Rating Details | |
2023-06-12 20:41:46 -0500 | Rating Details | |
2023-06-12 20:39:10 -0500 | Rating Details | |
2023-06-12 19:52:13 -0500 | Rating Details | |
2023-06-12 19:41:43 -0500 | Rating Details | |
2023-06-14 08:12:33 -0500 | Rating Details | |
2023-06-13 22:56:39 -0500 | Rating Details | |
2023-06-13 21:01:57 -0500 | Rating Details | |
2023-06-13 20:14:36 -0500 | Rating Details | |
2023-06-13 19:32:32 -0500 | Rating Details | |
2023-06-15 14:10:33 -0500 | Rating Details | |
2023-06-15 10:02:13 -0500 | Rating Details | |
2023-06-18 12:20:13 -0500 | Rating Details | |
2023-06-16 03:26:45 -0500 | Rating Details | |
2023-06-16 00:39:57 -0500 | Rating Details | |
2023-06-15 19:48:35 -0500 | Rating Details | |
2023-06-24 22:05:14 -0500 | Rating Details | |
2023-06-29 14:54:58 -0500 | Rating Details |